10 Dec 2025capital raising announcement▲ GoodMajor
Almonty closed its upsized US offering with the underwriters' over-allotment option exercised in full: 20,700,000 shares at US$6.25, for gross proceeds of US$129,375,000. This resolves the open question on the over-allotment (previously 18,000,000 shares and US$112.5M before the option) and means more dilution than the pricing announcement alone showed. The CEO said the company is fully capitalized for the projects in the supplement, has no present intention of further raises under the base prospectus, and intends to move to withdraw it. Use of proceeds is unchanged and still does not mention the tungsten oxide facility.
What it means for a shareholder
20.7m new shares at US$6.25 to raise about US$129m. Shares on issue before the raise aren't in the record, so the dilution can't be worked out.
Create a free account to see this worked out for your own holding.